CN102548546A - 用于施用芬太尼或其类似物的透皮治疗系统 - Google Patents

用于施用芬太尼或其类似物的透皮治疗系统 Download PDF

Info

Publication number
CN102548546A
CN102548546A CN2010800409634A CN201080040963A CN102548546A CN 102548546 A CN102548546 A CN 102548546A CN 2010800409634 A CN2010800409634 A CN 2010800409634A CN 201080040963 A CN201080040963 A CN 201080040963A CN 102548546 A CN102548546 A CN 102548546A
Authority
CN
China
Prior art keywords
polyisobutylene
weight
layer
active component
transdermal therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800409634A
Other languages
English (en)
Chinese (zh)
Inventor
诺哈·萨尔曼
比约恩·舒拉德
英戈·托伊奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luye Pharma AG
Original Assignee
Acino AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41559211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102548546(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino AG filed Critical Acino AG
Publication of CN102548546A publication Critical patent/CN102548546A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN2010800409634A 2009-09-14 2010-09-14 用于施用芬太尼或其类似物的透皮治疗系统 Pending CN102548546A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170223A EP2295046B1 (de) 2009-09-14 2009-09-14 Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
EP09170223.3 2009-09-14
PCT/EP2010/063433 WO2011029948A2 (de) 2009-09-14 2010-09-14 Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon

Publications (1)

Publication Number Publication Date
CN102548546A true CN102548546A (zh) 2012-07-04

Family

ID=41559211

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800409634A Pending CN102548546A (zh) 2009-09-14 2010-09-14 用于施用芬太尼或其类似物的透皮治疗系统

Country Status (10)

Country Link
US (1) US20120209223A1 (enExample)
EP (2) EP2295046B1 (enExample)
JP (1) JP2013504546A (enExample)
CN (1) CN102548546A (enExample)
AU (1) AU2010294160A1 (enExample)
BR (1) BR112012005629A2 (enExample)
CA (1) CA2773008A1 (enExample)
IN (1) IN2012DN01225A (enExample)
MX (1) MX2012002727A (enExample)
WO (1) WO2011029948A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825426A (zh) * 2015-05-26 2015-08-12 韩晓明 双相褪黑素贴剂
CN111419827A (zh) * 2018-12-21 2020-07-17 宜昌人福药业有限责任公司 一种阿芬太尼透皮给药的药物组合物及其制备方法和应用

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5558074B2 (ja) * 2009-10-15 2014-07-23 日東電工株式会社 塗膜保護シート
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
EP2599478A1 (de) * 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US9072682B2 (en) * 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US10377114B2 (en) * 2017-04-20 2019-08-13 Inep Europe Sarl Method for making a transdermal fentanyl patch with even drug crystal distribution
EP3612170A4 (en) * 2017-04-19 2021-01-27 Inep Europe Sarl PROCESS FOR MANUFACTURING A TRANSDERMAL FENTANYPE PLASTER WITH EVEN DISTRIBUTION OF MEDICINAL CRYSTALS
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1640387A (zh) * 2004-01-15 2005-07-20 财团法人工业技术研究院 经皮吸收贴片及其制造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
NZ528148A (en) 2001-03-16 2006-02-24 Alza Corp Transdermal patch for administering fentanyl
JP4758101B2 (ja) 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
ES2315600T3 (es) 2004-08-09 2009-04-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Conjugados de albumina que contienen un ligador glucuronico.
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
JP5064391B2 (ja) * 2006-07-14 2012-10-31 久光製薬株式会社 貼付剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1640387A (zh) * 2004-01-15 2005-07-20 财团法人工业技术研究院 经皮吸收贴片及其制造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陆彬等: "《药物新剂型与新技术》", 31 July 2005, article "无", pages: 574 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825426A (zh) * 2015-05-26 2015-08-12 韩晓明 双相褪黑素贴剂
CN111419827A (zh) * 2018-12-21 2020-07-17 宜昌人福药业有限责任公司 一种阿芬太尼透皮给药的药物组合物及其制备方法和应用
CN111419827B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种阿芬太尼透皮给药的药物组合物及其制备方法和应用

Also Published As

Publication number Publication date
MX2012002727A (es) 2012-05-08
JP2013504546A (ja) 2013-02-07
WO2011029948A2 (de) 2011-03-17
EP2477616B1 (de) 2013-08-14
IN2012DN01225A (enExample) 2015-04-10
BR112012005629A2 (pt) 2016-08-02
WO2011029948A3 (de) 2011-10-13
EP2295046B1 (de) 2012-12-19
CA2773008A1 (en) 2011-03-17
US20120209223A1 (en) 2012-08-16
EP2295046A1 (de) 2011-03-16
AU2010294160A1 (en) 2012-04-05
EP2477616A2 (de) 2012-07-25

Similar Documents

Publication Publication Date Title
CN102548546A (zh) 用于施用芬太尼或其类似物的透皮治疗系统
AU2009240195B2 (en) Transdermal therapeutic system for administration of fentanyl or an analog thereof
KR101674240B1 (ko) 리바스티그민 또는 그의 유도체 투여용 경피 치료 시스템
EP1033978B1 (de) D2-agonist enthaltendes transdermales therapeutisches system zur behandlung des parkinson-syndroms und verfahren zu seiner herstellung
KR101016838B1 (ko) 로티고틴 투여를 위한 향상된 경피 송달 시스템
US8246980B2 (en) Transdermal delivery system
US20090041831A1 (en) Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
KR20010036685A (ko) 펜타닐을 함유하는 매트릭스형 경피투여제
EP2797588B1 (de) Transdermales therapeutisches system mit geringer neigung zur spontankristallisation
CZ20014514A3 (cs) Mikrorezervoárový systém na bázi polysiloxanů a ambifilních rozpouątědel
CN100558350C (zh) 改良透皮递药系统
MX2014005437A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
WO2017180529A1 (en) Double disk transdermal process
EP1299091B1 (de) Matrixkontrolliertes transdermales system für stabile derivate der ace-hemmer
HUT77383A (hu) Szkopolamint tartalmazó tapasz
US10076502B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
EP4520318A1 (en) Transdermal therapeutic system of lumateperone
EP1196151A1 (en) Transdermal therapeutic system for administering a calcium antagonist
AU2013242824A1 (en) Transdermal therapeutic system for administration of fentanyl or an analog thereof
DE112024000733T5 (de) Transdermales therapeutisches system zur transdermalen verabreichung von huperzin a
HK1151746A (en) Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
HK1062649A (en) Improved transdermal delivery system
HK1170945A (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120704